Kodiak Sciences director granted 17,731 stock options
Kodiak Sciences Inc. director Yang Taiyin received a new stock option grant as part of equity compensation.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Kodiak Sciences Inc. director Yang Taiyin received a new stock option grant as part of equity compensation. The award covers 17,731 stock options for common stock at an exercise price of $38.96 per share, with no cash paid at grant.
All 17,731 options will vest in a single tranche on the earlier of June 30, 2027 or one day before Kodiak Sciences’ next annual shareholder meeting after the grant date, provided Yang continues serving on the board through the applicable vesting date. Following this grant, Yang holds 17,731 stock options directly.
Insider Trade Summary
Grant/Award: 17,731 shares
Grant/Award
1 txn
Insider
Yang Taiyin
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 17,731 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 17,731 contracts (Direct)
Footnotes (1)
- F1. One hundred percent (100%) of the shares subject to the option shall vest upon the earlier of June 30, 2027 or one (1) day prior to the Issuer's next annual meeting occurring after the grant date, in each case, provided the Reporting Person continues to serve as a member of the Issuer's board of directors through the applicable vesting date.
Key Figures
Options granted: 17,731 options
Exercise price: $38.96 per share
Underlying shares: 17,731 shares
+3 more
6 metrics
Options granted
17,731 options
Stock Option (Right to Buy) grant to director Yang Taiyin
Exercise price
$38.96 per share
Exercise price for underlying Kodiak Sciences common stock
Underlying shares
17,731 shares
Common stock underlying the stock option award
Post-grant options held
17,731 options
Total derivative securities following the reported transaction
Option expiration
June 29, 2036
Expiration date of the stock option award
Vesting date reference
June 30, 2027
Latest vesting date, or one day before next annual meeting
Key Terms
Stock Option (Right to Buy), exercise price, vesting, annual meeting
4 terms
Stock Option (Right to Buy) financial
"security_title: "Stock Option (Right to Buy)""
exercise price financial
"conversion_or_exercise_price: "38.9600""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"shares subject to the option shall vest upon the earlier of June 30, 2027"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
annual meeting financial
"one (1) day prior to the Issuer's next annual meeting occurring after the grant date"
A company's annual meeting is a yearly gathering where owners (shareholders) and the board review performance, ask questions, and vote on key matters like electing directors, approving auditor choices, and sometimes setting pay or dividend policies. For investors it matters because decisions made and votes cast can change who runs the company, influence strategy and payouts, and affect the value or direction of their investment—similar to a homeowners’ meeting where rules and leaders that shape your property’s value are decided.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Kodiak Sciences (KOD) report for director Yang Taiyin?
Kodiak Sciences reported a stock option grant to director Yang Taiyin. He received 17,731 options to buy common shares at $38.96 each, representing a compensation award rather than an open-market share purchase or sale, according to the Form 4 disclosure and related footnote.
How many Kodiak Sciences (KOD) stock options were granted to Yang Taiyin and at what price?
Yang Taiyin was granted 17,731 stock options for Kodiak Sciences common stock. The options have an exercise price of $38.96 per share, meaning he can purchase shares at that price once the options are vested and exercised, subject to the award’s terms and continued board service.
When do Yang Taiyin’s Kodiak Sciences (KOD) stock options vest?
All of Yang Taiyin’s 17,731 Kodiak Sciences stock options vest in a single installment. Vesting occurs on the earlier of June 30, 2027, or one day before the company’s next annual meeting after the grant date, assuming he remains on the board through that vesting date.
Is Yang Taiyin’s Kodiak Sciences (KOD) Form 4 transaction a stock sale or purchase?
The Form 4 shows a stock option grant, not a market trade. Yang Taiyin acquired 17,731 options with a $38.96 exercise price as compensation, and no open-market buying or selling of Kodiak Sciences common shares is reported in this filing for the transaction date.
What is the expiration date of Yang Taiyin’s Kodiak Sciences (KOD) stock options?
The granted stock options to Yang Taiyin expire on June 29, 2036. After that date, any unexercised options become invalid. The long-dated term gives him a substantial window to exercise the 17,731 options once they vest and if exercising is otherwise permitted.
AI-generated analysis. How Rhea-AI works. Not financial advice.
